LWW lands The Cancer Journal

Share this article:
Wolters Kluwer Health has picked up The Cancer Journal from Jones & Bartlett.

The journal will be published by Lippincott Williams & Wilkins under the new name The Cancer Journal: The Journal of Principles and Practices of Oncology.

Jeff McCaulley, president and CEO of Wolters Kluwer Health, said: “The acquisition of The Cancer Journal is congruent with our strategy to grow our leading positions by extending our proprietary content in the healthcare industry, especially in leading disease states and therapeutic areas.”

LWW also publishes The Journal of Clinical Oncology, Annals of Oncology and Cancer Nursing.

Share this article:
close

Next Article in News

Email Newsletters

More in News

Bayer drug gets orphan label

Bayer drug gets orphan label

The FDA designation is for an experimental, inhaled form of ciprofloxacin intended to treat a rare lung condition.

Lilly's cancer drug ramu granted gastric indication

Lilly's cancer drug ramu granted gastric indication

Ramucirumab received FDA approval today in advanced gastric cancer, a nod that could translate into $600 million in peak sales.

GSK, Novartis, Lilly play musical chairs

GSK, Novartis, Lilly play musical chairs

The three drugmakers rearranged part of the pharma universe Tuesday with a string of pipeline-altering deals.